Carolyn E. Taylor - Jul 16, 2021 Form 3 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)

Role
Director
Signature
/s/ Jessica Morris as attorney-in-fact
Stock symbol
TNXP
Transactions as of
Jul 16, 2021
Transactions value $
$0
Form type
3
Date filed
7/27/2021, 09:45 PM
Next filing
May 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TNXP Stock Option Jul 16, 2021 Common Stock 237K $0.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.